These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 8416373)

  • 21. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
    Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.
    Albini A; Fontanini G; Masiello L; Tacchetti C; Bigini D; Luzzi P; Noonan DM; Stetler-Stevenson WG
    AIDS; 1994 Sep; 8(9):1237-44. PubMed ID: 7528513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR.
    Caselli E; Menegazzi P; Bracci A; Galvan M; Cassai E; Di Luca D
    J Gen Virol; 2001 Aug; 82(Pt 8):1965-1970. PubMed ID: 11458004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
    Cannon P; Kim SH; Ulich C; Kim S
    J Virol; 1994 Mar; 68(3):1993-7. PubMed ID: 8107261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
    Kessler M; Mathews MB
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation.
    Kwak YT; Ivanov D; Guo J; Nee E; Gaynor RB
    J Mol Biol; 1999 Apr; 288(1):57-69. PubMed ID: 10329126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?
    Samaniego F; Pati S; Karp JE; Prakash O; Bose D
    J Natl Cancer Inst Monogr; 2001; (28):15-23. PubMed ID: 11158202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
    Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
    J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors.
    Daelemans D; De Clercq E; Vandamme AM
    J Virol Methods; 2001 Aug; 96(2):183-8. PubMed ID: 11445148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of PDGF-B and PDGF receptor expression in the pathogenesis of Kaposi's sarcoma in AIDS.
    Pistritto G; Ventura L; Mores N; Lacal PM; D'Onofrio C
    Antibiot Chemother (1971); 1994; 46():73-87. PubMed ID: 7826042
    [No Abstract]   [Full Text] [Related]  

  • 33. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
    J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.
    Popik W; Pitha PM
    J Virol; 1994 Mar; 68(3):1324-33. PubMed ID: 8107197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
    Schafer SL; Vlach J; Pitha PM
    J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
    Liou LY; Herrmann CH; Rice AP
    J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.
    Missé D; Gajardo J; Oblet C; Religa A; Riquet N; Mathieu D; Yssel H; Veas F
    AIDS; 2005 Jun; 19(9):897-905. PubMed ID: 15905670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.
    Remenick J; Radonovich MF; Brady JN
    J Virol; 1991 Oct; 65(10):5641-6. PubMed ID: 1654461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.